Other News

Clarius Receives CE Mark Certification for Seven New Ultra-Portable Wireless Ultrasound Scanners for Apple and Android Devices

Miniaturized to the size of an iPhone, the third-generation ultrasound scanners make high-definition ultrasound affordable for more doctors across specialties in Europe VANCOUVER, British Columbia–(BUSINESS WIRE)–Clarius Mobile Health is first to introduce a third-generation product line of high-performance wireless ultrasound scanners in the European Union and United Kingdom. Now 30% lighter […]

AtriCure Reports First Quarter 2022 Financial Results

MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced first quarter 2022 financial results. “Our team delivered exceptional first quarter performance, with broad-based growth across all key products,” said Michael Carrel, […]

DiA Imaging Analysis Named one of FAST COMPANY’S 2022 World Changing Ideas in Health Category

FAST COMPANY honored DiA’s innovative LVivo Toolbox software leveraging AI to automate the way clinicians analyze ultrasound images BEER SHEVA, Israel, May 4, 2022 /PRNewswire/ — DiA Imaging Analysis – a global leading provider of ultrasound AI-based software solutions – has been recognized in the health category for Fast Company‘s World Changing Ideas Awards.  DiA’s AI-powered cardiac and abdominal ultrasound analysis software allows clinicians with […]

CytoSorbents Reports First Quarter 2022 Results and Revises 2022 Outlook

Q1 2022 total revenue was $8.7 million, including product sales of $7.9 million.  Core non-COVID-19 product sales were an estimated $7.6 million, and on a constant currency basis were comparable to core product sales a year ago.  Product gross margins were 80%. MONMOUTH JUNCTION, N.J., May 3, 2022 /PRNewswire/ — CytoSorbents Corporation (NASDAQ: CTSO), a leader in the […]

CathVision Announces FDA Clearance of ECGenius™ High-Fidelity, Low-Noise EP Recording Technology

ECGenius Sets a New Standard for ECG Signal Detection, Interpretation and Therapy Support COPENHAGEN, Denmark , May 4, 2022 /PRNewswire/ — CathVision, a medical technology company developing innovative electrophysiology solutions designed to enhance clinical decision making in the EP lab, today announced the FDA 510(k) clearance of the ECGenius EP Recording System. ECGenius, the […]

Ionis reports first quarter financial results and recent business achievements

On track to achieve 2022 financial guidance Webcast today, May 4, 2022, at 11:30 a.m. Eastern Time CARLSBAD, Calif., May 4, 2022 /PRNewswire/ — Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported financial results for the first quarter of 2022 and recent business achievements. “We are off to a strong start this year highlighted by progress in our […]

Leveraging the science of hibernation to improve human heart health

EMERYVILLE, Calif., May 4, 2022 /PRNewswire/ — Discovering new ways to treat heart and lung diseases by tapping into the natural disease resistance of hibernating animals is the focus of a new partnership between Monash University and Fauna Bio, a U.S. biotechnology company. Hibernation requires mechanisms of self-healing and tissue repair to endure […]

3M Littmann CORE Digital Stethoscope Honored in Fast Company’s 2022 World Changing Ideas Awards

ST. PAUL, Minn., May 3, 2022 /PRNewswire/ — 3M™ Littmann® today announced its 3M™ Littmann® CORE Digital Stethoscope received honorable mention accolades in the health category of the 2022 Fast Company World Changing Ideas global awards program recognizing companies, products and initiatives that support innovation for the public good and tackle social inequality, climate change and public health […]

TransMedics Reports First Quarter 2022 Financial Results

ANDOVER, Mass., May 3, 2022 /PRNewswire/ — TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today reported financial results for the quarter ended March 31, 2022. Recent Highlights Net revenue of $15.9 million in the first quarter of 2022, […]